In terms of protein IHC staining, Fisher et al. [26] have shown that high tumor RRM2 expression was an independent negative prognostic factor for early recurrence and decreased survival in patients with early-stage PDAC, both when analyzing the entire cohort (n = 95) and the subset of patients receiving adjuvant therapy (n = 74). Here, RRM2 is linked to neoplasm.